(株)カイノスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4556/E00977 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/07/10 | 日証協 | 205,100株 | -9.93% | 21,700株 | -49.42% | 172,428株 | -5.95% | 22,500株 | -22.15% |
2020/07/03 | 日証協 | 227,700株 | +4.98% | 42,900株 | -24.2% | 183,328株 | +10.96% | 28,900株 | -61.93% |
2020/06/26 | 日証協 | 216,900株 | -2.65% | 56,600株 | +243.03% | 165,217株 | -1.37% | 75,911株 | +305.72% |
2020/06/12 | 日証協 | 236,200株 | +9.86% | 75,200株 | +1.21% | 191,417株 | +18.22% | 71,600株 | +48.86% |
2020/06/05 | 日証協 | 215,000株 | -17.75% | 74,300株 | +55.77% | 161,917株 | -22.83% | 48,100株 | +14.52% |
2020/05/29 | 日証協 | 261,400株 | +3.2% | 47,700株 | +41.4% | 209,817株 | +10.95% | 42,000株 | -0.47% |
2020/05/22 | 日証協 | 253,300株 | +3.98% | 33,735株 | -68.41% | 189,117株 | +9.05% | 42,200株 | -34.5% |
2020/05/15 | 日証協 | 243,600株 | -6.63% | 106,800株 | +307.63% | 173,428株 | -2.96% | 64,431株 | +956.25% |
2020/05/08 | 日証協 | 260,900株 | +14.13% | 26,200株 | -66.84% | 178,726株 | +10.56% | 6,100株 | -86.26% |
2020/05/01 | 日証協 | 228,600株 | +8.29% | 79,000株 | +329.35% | 161,657株 | +4.12% | 44,409株 | +131.19% |
2020/04/24 | 日証協 | 211,100株 | -8.38% | 18,400株 | +15.72% | 155,257株 | -2.78% | 19,209株 | +110.62% |
2020/04/17 | 日証協 | 230,400株 | -20.96% | 15,900株 | +62.24% | 159,700株 | -24.36% | 9,120株 | +36.94% |
2020/04/10 | 日証協 | 291,500株 | +2.03% | 9,800株 | -62.31% | 211,120株 | +1.33% | 6,660株 | -77.77% |
2020/04/03 | 日証協 | 285,700株 | +3.22% | 26,000株 | -68.48% | 208,351株 | +2.93% | 29,965株 | +32% |
2020/03/27 | 日証協 | 276,800株 | +5.81% | 82,500株 | +1078.57% | 202,418株 | -12.91% | 22,701株 | +260.33% |
2020/03/19 | 日証協 | 261,600株 | -19.45% | 7,000株 | -90.95% | 232,420株 | -18.08% | 6,300株 | -92.95% |
2020/03/13 | 日証協 | 324,748株 | -24.55% | 77,348株 | +7.99% | 283,720株 | -17.31% | 89,338株 | +88.48% |
2020/03/06 | 日証協 | 430,405株 | -2.96% | 71,628株 | -47.67% | 343,117株 | +0.17% | 47,400株 | -30.53% |
2020/02/28 | 日証協 | 443,521株 | +8.19% | 136,865株 | -38.21% | 342,518株 | +2.91% | 68,230株 | -24.08% |
※株式分割は考慮していませんのでご注意ください。
Page Top